Leukapheresis Market Size, Share & Trends Analysis Report By Product (Leukapheresis Devices, Leukapheresis Disposables), By Application, By End-use, By Region, And Segment Forecasts, 2024 - 2030
Leukapheresis Market Size & Trends
The global leukapheresis market size was estimated at USD 191.8 million in 2023 and is projected to grow at a CAGR of 10.94% from 2024 to 2030. The increasing prevalence of blood disorders and autoimmune diseases, technological advancements in leukapheresis procedures and growing demand for personalized medicine are expected to drive the market growth. Moreover, the increasing investments in research and development activities is further contributing to the market growth.
The rising incidence of blood disorders like leukemia, lymphoma, and autoimmune diseases such as rheumatoid arthritis and multiple sclerosis are significantly driving the market growth. For instance, the Leukemia & Lymphoma Society reports that an estimated total of 184,720 people in the U.S. are expected to receive a diagnosis of leukemia, lymphoma, or myeloma in 2023. Similarly, in May 2023, a study in The Lancet involving 22 million people finds autoimmune disorders affect 1 in 10 individuals, highlighting the influence of socioeconomic, seasonal, and regional factors, and offers insights into the causes of these diseases including Rheumatoid arthritis, Type 1 diabetes, and Multiple sclerosis. Thus, propelling the demand for leukapheresis over the forecast period.
The advancements in leukapheresis technologies are improving the efficiency, safety, and outcomes of the procedure. The introduction of automated systems, continuous flow centrifugation systems, and closed-system devices is expected to enhance the precision and effectiveness of leukapheresis. Thereby reducing the procedure times, minimize donor discomfort, and optimize cell collection yields. In October 2022, the Clinical Applications Committee of The American Society for Apheresis (ASFA), along with the IEC Therapy Subcommittee, AABB, and various other organizations, prepared a white paper. This document outlines guidelines for performing leukapheresis to retrieve mononuclear cells from pediatric and adult patients who are part of immune effector cell therapies, whether for commercial endeavors or research initiatives. Thus, anticipated to propel the market growth over the forecast period.
The shift towards personalized medicine approaches that tailor treatment strategies to individual patient profiles are fueling the demand for leukapheresis procedures. Leukapheresis plays a crucial role in cell-based therapies, such as chimeric antigen receptor (CAR) T-cell therapy and stem cell transplantation. In December 2023, an article in Transfusion and Apheresis Science underscored the challenges in manufacturing CAR-T cells, beginning with the extraction of T cells through leukapheresis from peripheral blood. The article emphasized the critical role of an effective leukapheresis product in achieving successful CAR-T cell therapy and highlighted the significance of comprehending the factors that impact T cell quality.
Global Leukapheresis Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global leukapheresis market report based on product, application, end-use, and region.
- Product Outlook (Revenue, USD Million, 2018 - 2030)
- Leukapheresis Devices
- Centrifugal Devices
- Membrane Separators
- Leukapheresis Disposables
- Application Outlook (Revenue, USD Million, 2018 - 2030)
- Research Application
- Cancer Research
- Immunology Research
- Others
- Therapeutics Application
- Hematologic Disorders
- Autoimmune Diseases
- Others
- End Use Outlook (Revenue, USD Million, 2018 - 2030)
- Blood Centers
- Academic & Research Institutes
- Pharmaceutical & Biotechnology Companies
- Hospitals & Clinics
- Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
- Chapter 1. Methodology and Scope
- 1.1. Market Segmentation and Scope
- 1.2. Market Definitions
- 1.2.1. Product
- 1.2.2. Application
- 1.2.3. End Use
- 1.3. Information analysis
- 1.4. Market formulation & data visualization
- 1.5. Data validation & publishing
- 1.6. Information Procurement
- 1.6.1. Primary Research
- 1.7. Information or Data Analysis
- 1.8. Market Formulation & Validation
- 1.9. Market Model
- 1.10. Objectives
- Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
- Chapter 3. Leukapheresis Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. The increasing prevalence of blood disorders and autoimmune diseases
- 3.2.1.2. Technological advancements in leukapheresis procedures
- 3.2.1.3. Growing demand for personalized medicine
- 3.2.1.4. Rising investments in research& development
- 3.2.2. Market restraint analysis
- 3.2.2.1. High equipment costs
- 3.3. Leukapheresis Market Analysis Tools
- 3.3.1. Industry Analysis - Porter’s
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
- Chapter 4. Leukapheresis Market: Product Estimates & Trend Analysis
- 4.1. Product Segment Dashboard
- 4.2. Global Leukapheresis Market Product Movement Analysis
- 4.3. Global Leukapheresis Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Leukapheresis Devices
- 4.4.1. Leukapheresis devices market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.2. Centrifugal Devices
- 4.4.2.1. Centrifugal Devices market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.4.3. Membrane Separators
- 4.4.3.1. Membrane separators market estimates and forecasts, 2018 to 2030 (USD Million)
- 4.5. Leukapheresis Disposables
- 4.5.1. Leukapheresis disposables market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 5. Leukapheresis Market: Application Estimates & Trend Analysis
- 5.1. Application Segment Dashboard
- 5.2. Global Leukapheresis Market Application Movement Analysis
- 5.3. Global Leukapheresis Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Research Application
- 5.4.1. Research application market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.2. Cancer Research
- 5.4.2.1. Cancer research market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.3. Immunology Research
- 5.4.3.1. Immunology research market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.4.4. Others
- 5.4.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5. Therapeutics Application
- 5.5.1. Therapeutics application market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5.2. Hematologic Disorders
- 5.5.2.1. Hematologic disorders market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5.3. I Autoimmune Diseases
- 5.5.3.1. Autoimmune diseases market estimates and forecasts, 2018 to 2030 (USD Million)
- 5.5.4. Others
- 5.5.4.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 6. Leukapheresis Market: End-use Estimates & Trend Analysis
- 6.1. End-use Segment Dashboard
- 6.2. Global Leukapheresis Market End-use Movement Analysis
- 6.3. Global Leukapheresis Market Size & Trend Analysis, by End-use, 2018 to 2030 (USD Million)
- 6.4. Blood Centers
- 6.4.1. Blood centers institutes market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.5. Academic & Research Institutes
- 6.5.1. Academic & research institutes market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.6. Pharmaceutical & Biotechnology Companies
- 6.6.1. Pharmaceutical & biotechnology companies market estimates and forecasts, 2018 to 2030 (USD Million)
- 6.7. Hospitals & Clinics
- 6.7.1. Hospitals & clinics market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 7. Leukapheresis Market: Regional Estimates & Trend Analysis by Product, Application, and End Use
- 7.1. Regional Market Share Analysis, 2023 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.4. North America
- 7.4.1. North America market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.2. U.S.
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Regulatory framework
- 7.4.2.3. Competitive scenario
- 7.4.2.4. U.S. market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.3. Canada
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Regulatory framework
- 7.4.3.3. Competitive scenario
- 7.4.3.4. Canada market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.4.4. Mexico
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Regulatory framework
- 7.4.4.3. Competitive scenario
- 7.4.4.4. Mexico market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5. Europe
- 7.5.1. Europe market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.2. UK
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Regulatory framework
- 7.5.2.3. Competitive scenario
- 7.5.2.4. UK market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.3. Germany
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Regulatory framework
- 7.5.3.3. Competitive scenario
- 7.5.3.4. Germany market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.4. France
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Regulatory framework
- 7.5.4.3. Competitive scenario
- 7.5.4.4. France market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.5. Italy
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Regulatory framework
- 7.5.5.3. Competitive scenario
- 7.5.5.4. Italy market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.6. Spain
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Regulatory framework
- 7.5.6.3. Competitive scenario
- 7.5.6.4. Spain market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.7. Norway
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Regulatory framework
- 7.5.7.3. Competitive scenario
- 7.5.7.4. Norway market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.8. Sweden
- 7.5.8.1. Key country dynamics
- 7.5.8.2. Regulatory framework
- 7.5.8.3. Competitive scenario
- 7.5.8.4. Sweden market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.5.9. Denmark
- 7.5.9.1. Key country dynamics
- 7.5.9.2. Regulatory framework
- 7.5.9.3. Competitive scenario
- 7.5.9.4. Denmark market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Regulatory framework
- 7.6.2.3. Competitive scenario
- 7.6.2.4. Japan market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Regulatory framework
- 7.6.3.3. Competitive scenario
- 7.6.3.4. China market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Regulatory framework
- 7.6.4.3. Competitive scenario
- 7.6.4.4. India market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.5. Australia
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Regulatory framework
- 7.6.5.3. Competitive scenario
- 7.6.5.4. Australia market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.6. South Korea
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Regulatory framework
- 7.6.6.3. Competitive scenario
- 7.6.6.4. South Korea market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Regulatory framework
- 7.6.7.3. Competitive scenario
- 7.6.7.4. Thailand market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Regulatory framework
- 7.7.2.3. Competitive scenario
- 7.7.2.4. Brazil market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Regulatory framework
- 7.7.3.3. Competitive scenario
- 7.7.3.4. Argentina market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.8. MEA
- 7.8.1. MEA market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Regulatory framework
- 7.8.2.3. Competitive scenario
- 7.8.2.4. South Africa market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Regulatory framework
- 7.8.3.3. Competitive scenario
- 7.8.3.4. Saudi Arabia market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key country dynamics
- 7.8.4.2. Regulatory framework
- 7.8.4.3. Competitive scenario
- 7.8.4.4. UAE market estimates and forecasts, 2018 to 2030 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key country dynamics
- 7.8.5.2. Regulatory framework
- 7.8.5.3. Competitive scenario
- 7.8.5.4. Kuwait market estimates and forecasts, 2018 to 2030 (USD Million)
- Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2023
- 8.4. Company Profiles/Listing
- 8.4.1. Charles River Laboratories International, Inc.
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Adacyte Therapeutics
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. AllCells, LLC
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Asahi Kasei Medical
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Haemonetics Corporation
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. Macopharma
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. Cerus Corporation
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. SB-Kawasumi Laboratories, Inc.
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. StemExpress, LLC.
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Lonza Group AG
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product benchmarking
- 8.4.10.4. Strategic initiatives
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook